Pay attention to your daily eating habits and hydration levels to identify patterns influencing hunger and fullness
The Numbers That Matter: In the landmark SURMOUNT-5 trial published in the New England Journal of Medicine in May 2025, participants taking tirzepatide lost an average of 20.2% of their body weight over 72 weeks, compared to 13.7% with semaglutide
Zhang T, Zhu X, Wu H, Jiang K, Zhao G, Shaukat A, et al
But that business exists not because Hims has developed and gained approval for such a drug, but rather due to a regulatory quirk: if the FDA determines there is a shortage of a particular drug, so-called compounding pharmacies can produce non-brand name versions of FDA-approved drugs, which companies like Hims can then offer patients at a cheaper price than name-brand versions
If it needs help, gently swirl or roll the vial
The information provided on this page is for educational purposes only and should not replace medical advice from a qualified healthcare provider